Intellia Therapeutics, Inc. (NTLA)
11.55
+0.13
(+1.14%)
USD |
NASDAQ |
Oct 19, 14:03
Intellia Therapeutics Cash from Operations (Annual) : -394.74M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -394.74M |
| December 31, 2024 | -348.88M |
| December 31, 2023 | -394.09M |
| December 31, 2022 | -333.29M |
| December 31, 2021 | -225.03M |
| December 31, 2020 | -49.91M |
| Date | Value |
|---|---|
| December 31, 2019 | -103.24M |
| December 31, 2018 | -61.26M |
| December 31, 2017 | -65.28M |
| December 31, 2016 | 36.11M |
| December 31, 2015 | -1.763M |
| December 31, 2014 | -2.322M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Twist Bioscience Corp. | -47.63M |
| Beam Therapeutics, Inc. | -345.10M |
| Prime Medicine, Inc. | -162.56M |
| 10X Genomics, Inc. | 136.05M |
| Moderna, Inc. | -1.873B |